Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
80 studies found for:    "Retinopathy of prematurity"
Show Display Options
Rank Status Study
1 Enrolling by invitation Enteral Administration of Docosahexaenoic Acid to Prevent Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Dietary Supplement: docosahexaenoic acid;   Dietary Supplement: sunflower oil
2 Unknown  Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome
Condition: Retinopathy of Prematurity
Intervention: Drug: intravitreal injection
3 Active, not recruiting Phase 1 Trial of Bevacizumab Treatment for Severe Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
4 Completed A Fatty Acids Study in Preventing Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: SMOFlipid;   Drug: Clinoleic
5 Unknown  Erythropoietin and Early Iron Supplement and Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: erythropoietin and early iron supplements
6 Withdrawn Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
7 Completed Pain Response During Examination for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Behavioral: suck 12.5% dextrose in water 5 minutes before the procedure
8 Completed
Has Results
Oral Propranolol Versus Placebo for Early Stages of Retinopathy of Prematurity: A Randomized and Prospective Study
Condition: Retinopathy of Prematurity
Interventions: Drug: propranolol;   Drug: sucrose 5%
9 Suspended Ultrasound to Detect Evidence for Retinal Detachment in Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Procedure: Ultrasound examination
10 Recruiting RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Ranibizumab;   Procedure: Laser therapy
11 Unknown  The Early Treatment for Retinopathy of Prematurity Study (ETROP)
Condition: Retinopathy of Prematurity
Intervention: Procedure: retinal ablation
12 Completed Lucentis to Treat Retinopathy of Prematurity (ROP) 3 Plus Disease
Condition: Retinopathy of Prematurity
Intervention: Drug: intravitreal injection of 0.03ml ranibizumab
13 Unknown  A Scan Ultrasonography in the Evaluation of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention:
14 Terminated Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Bevacizumab
15 Completed Safety and Efficacy of Propranolol in Newborns With Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Intervention: Drug: Propranolol
16 Recruiting Incidence, Risk Factors and Severity of Retinopathy of Prematurity (ROP) in Turkey
Condition: Retinopathy of Prematurity
Intervention:
17 Completed Sucrose Analgesia for the Reduction of Pain During Retinopathy of Prematurity Screening
Condition: Retinopathy of Prematurity
Interventions: Other: Sucrose;   Other: Sterile water
18 Recruiting Study of the Implication of Omega-3 Polyunsaturated Fatty Acids in Retinopathy of Prematurity in New-born Infants
Condition: Retinopathy of Prematurity
Interventions: Other: RETCAM;   Biological: Blood samples
19 Active, not recruiting
Has Results
Bevacizumab Eliminates the Angiogenic Threat for Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP
20 Completed IGF-1/IGFBP3 Prevention of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity (ROP)
Intervention: Drug: rhIGF-I/rhIGFBP-3

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.